← Blog

Hungarian Stocks: A Guide to the Budapest Stock Exchange (BÉT)

·9 min read·Nico Mena

The Budapest Stock Exchange hosts some of Central Europe's most interesting listed companies — including OTP Bank, the region's dominant independent bank, and MOL Group, an integrated energy major. Here's how to approach Hungarian equities.

The Budapest Stock Exchange (BÉT — Budapesti Értéktőzsde) is one of Central Europe's most established equity markets, home to OTP Bank — arguably the most interesting independent bank in CEE — and MOL Group, a fully integrated energy company with operations across a dozen countries. For European investors, Hungary offers exposure to CEE economic growth through a handful of genuinely large-cap, well-governed businesses, at valuations that consistently trade below Western European equivalents.

Last updated: June 2026.


What the Budapest Stock Exchange covers

BUX Index: The headline benchmark, covering the 12–18 most liquid and largest companies by market capitalisation. The BUX is highly concentrated — the top four companies (OTP Bank, MOL Group, Richter Gedeon, Magyar Telekom) account for approximately 75–80% of total index weight.

BUX Mid: A broader mid-cap index covering companies below the BUX threshold. Lower liquidity but includes several interesting industrial and financial names.

Xtend: The BÉT's alternative market for smaller companies, with lighter listing requirements. The Xtend market covers approximately 30–40 smaller Hungarian businesses across a range of sectors.

Premium Market: The top tier with the strictest transparency and reporting requirements. BUX constituents primarily come from this segment.

Market size

Total market capitalisation on the BÉT is approximately €25–35 billion, making it the third-largest Central European exchange after Warsaw (GPW) and Prague (PSE). The market is highly concentrated: OTP Bank alone accounts for approximately 25–30% of total market cap.


Key sectors and major companies

Banking — OTP Bank

OTP Bank: Hungary's largest bank and the most significant independent banking institution in Central and Eastern Europe. Unlike most major CEE banks — which are subsidiaries of Western European parents (Erste Group, Société Générale, UniCredit) — OTP is Hungarian-controlled and independently listed.

OTP has pursued an aggressive regional expansion strategy, acquiring banks across Bulgaria, Serbia, Slovenia, Croatia, Albania, Montenegro, Russia (divesting post-2022), and more recently in Uzbekistan and Moldova. It is now one of the largest banks in the Balkans and a meaningful CEE retail banking franchise.

Screening note for OTP Bank: OTP trades at P/Book ratios of 1.0–1.8x depending on sentiment, with ROE consistently in the 15–22% range — among the highest of any listed CEE bank. For European bank screening, OTP is a consistent candidate combining quality metrics with CEE growth exposure.

Magyar Bankholding: A newer entity created by the merger of Budapest Bank, MKB Bank, and Takarékbank — forming Hungary's second-largest domestic bank. Listed on BÉT as a significant mid-cap financial.

Energy — MOL Group

MOL Group: Hungary's integrated oil and gas company, covering upstream exploration and production (in Hungary, Croatia, Pakistan, and elsewhere), refining (two major refineries in Hungary and Slovakia), and a large network of retail fuel stations across CEE. MOL is one of the largest listed companies in CEE by revenue.

MOL is also investing in petrochemicals and early-stage energy transition businesses. Its CEE downstream presence — fuel stations and convenience retail — gives it a different revenue profile from pure upstream European energy producers.

Screening note for MOL: MOL trades at P/E and EV/EBITDA multiples significantly below Western European integrated oil majors like OMV or Neste. The discount reflects CEE risk premium and the complexity of its refining-heavy business model.

Pharmaceuticals — Richter Gedeon

Richter Gedeon: Hungary's pharmaceutical giant and one of the most significant generics and specialty pharma companies in CEE. Richter has a distinctive product focus in women's healthcare and neurological drugs, with products sold across Europe, Asia, and Latin America.

Richter is partially owned by the Russian state pharmaceutical company Gedeon Richter has significant historical ties to Russian markets, which has been a source of both growth and risk. It is one of the more genuinely international CEE businesses with a legitimate global product portfolio.

Screening note for Richter: Richter trades at lower multiples than Western European specialty pharma equivalents, reflecting its CEE headquarters discount and Russia exposure. For healthcare and pharma screening, Richter appears consistently in low-P/E European pharma screens.

Telecoms

Magyar Telekom: The Hungarian subsidiary of Deutsche Telekom, providing mobile (T-Mobile), broadband, and TV services across Hungary and North Macedonia. A regulated telecommunications business with predictable cash flows and a history of consistent dividends — when not subject to special government levies.

Telecom and government risk note: Hungarian telecoms and utilities have been subject to extraordinary sectoral levies and government interventions since 2010. This regulatory risk is specific to Hungary and must be factored into any Hungarian utility or telecom position.

Other notable names

4iG: A Hungarian technology conglomerate that has grown rapidly through acquisitions into telecoms, IT services, and space technology. State-connected company with significant government contracts. Higher risk profile than the blue-chip index names.

CIG Pannonia Life Insurance: A Hungarian life insurer, one of the few standalone listed insurance names in Central Europe. Niche, with limited international coverage.


Why consider Hungarian equities

OTP Bank's standalone franchise quality

Most CEE banking exposure available to international investors comes packaged with Western European parent risk (Erste, UniCredit, Société Générale). OTP provides direct exposure to CEE banking growth through an independently managed institution with a track record of regional expansion. Its ROE profile, growth trajectory, and price discipline are distinct from subsidiary-bank models.

Persistent valuation discount

Hungarian blue-chips trade at persistent discounts to Western European peers. The BUX P/E has historically run 7–11x, below German, French, or Swiss equivalents. Reasons include: the CEE risk premium, Hungary's complex political economy under the Orbán government (which introduces regulatory uncertainty), and limited international institutional ownership.

For value investors, the discount means quality businesses with strong fundamentals priced at below-average European multiples.

Pharmaceutical sector depth

Richter Gedeon provides access to a genuinely international specialty pharmaceutical business that would trade at higher multiples if headquartered in Switzerland or the UK. The CEE headquarters discount is structural and creates a persistent opportunity for investors willing to look past geography.


Currency risk: Hungarian Forint (HUF)

Hungary has not adopted the euro. The HUF is one of CEE's more volatile currencies. The exchange rate has fluctuated meaningfully over the past decade, with periods of significant depreciation relative to the EUR.

Key HUF considerations:

  • The Hungarian National Bank (MNB) has less credibility as an inflation fighter than the Czech CNB or Polish NBP
  • Hungary's fiscal policy under the current government has at times been expansionary, adding currency pressure
  • HUF/EUR exchange rate as of June 2026: approximately 395–405 HUF per EUR

For EUR-based investors, HUF volatility is a real factor. A 10% HUF depreciation against the EUR fully offsets a 10% HUF-denominated price gain. Factor currency risk into position sizing.


Key Hungarian market characteristics for screeners

Government and regulatory risk

Hungary's political environment creates a specific risk layer not present in most Western European equity markets. The government has imposed extraordinary sectoral levies on banks, telecoms, energy retailers, and other businesses on multiple occasions. OTP Bank, Magyar Telekom, and MOL have all been subject to special taxes that temporarily impair earnings.

This regulatory risk is not unique to Hungary in CEE — Poland and Romania have also imposed sectoral levies — but it is more systematic and prolonged in Hungary. Screen for this risk by applying a multi-year earnings average (3–5 years) rather than using single-year EPS, and apply an additional discount to regulated or government-adjacent businesses.

Liquidity adequate for blue chips

The BUX blue chips (OTP, MOL, Richter) have adequate daily trading volumes for retail investors. Outside the BUX, liquidity on the BUX Mid and Xtend markets is thin. Apply a minimum daily volume filter of €150,000+ for any systematic screen.


Screening Hungarian stocks: practical filters

BUX value screen:

  • Exchange: Budapest (BÉT)
  • P/E < 10
  • EV/EBITDA < 7
  • Dividend yield > 3%
  • Sort by: EV/EBITDA ascending

Hungarian banking screen:

  • Exchange: Budapest (BÉT)
  • Sector: Financials — Banks
  • P/Book < 1.5
  • ROE > 14%
  • Sort by: ROE descending

Hungarian quality screen:

  • Exchange: Budapest (BÉT)
  • ROIC > 12%
  • Operating margin > 10%
  • Revenue growth (3yr avg) > 5%
  • Sort by: ROIC descending

Open the European stock screener → — filter by Budapest exchange across all European markets. Free, no account required.


Key risks

Government and regulatory intervention. Hungary's government has imposed extraordinary levies on banks, telecoms, and energy companies on multiple occasions. This risk is ongoing and creates earnings uncertainty beyond normal business risk.

HUF currency volatility. The Forint is one of CEE's less stable currencies. Significant HUF depreciation episodes can substantially reduce EUR-denominated returns.

Index concentration. The BUX is heavily concentrated. OTP Bank alone represents 25–30% of the index. Stock-specific problems at OTP directly impact the market.

Russia exposure at Richter Gedeon. Richter has historically derived significant revenue from Russian markets. Geopolitical developments affecting Russia have direct earnings impact on Richter's revenue and distribution.


Frequently asked questions

What index covers Hungarian stocks?

The BUX is the primary benchmark for the Budapest Stock Exchange, covering the 12–18 most liquid large-cap companies. The BUX is heavily concentrated, with OTP Bank, MOL Group, Richter Gedeon, and Magyar Telekom collectively accounting for approximately 75–80% of its weight.

Is OTP Bank a good proxy for CEE banking growth?

OTP Bank is the most direct listed proxy for CEE banking growth through an independently-managed institution. Unlike most CEE banks, which are subsidiaries of Western European parents, OTP is controlled by Hungarian private interests and has pursued an independent regional expansion strategy. It is present in 10+ countries across CEE and the Balkans, delivering ROE consistently above 15%.

How does Hungary's currency risk compare to Poland or Romania?

The Hungarian Forint (HUF) has historically been one of the more volatile CEE currencies — more volatile than the Czech Koruna (CZK) and roughly comparable to the Polish Zloty (PLN) and Romanian Leu (RON). Investors should factor HUF exposure into position sizing and monitor Hungarian National Bank policy and fiscal developments.

Are Hungarian stocks accessible to EU investors?

Yes. The Budapest Stock Exchange is an EU-regulated market accessible through most European brokerages that offer CEE exchange coverage. Settlement is in HUF through standard EU settlement infrastructure.

What is Richter Gedeon and why is it listed in Budapest?

Richter Gedeon is Hungary's largest pharmaceutical company, founded in Budapest in 1901. Despite its global reach — with products distributed across Europe, CIS, Asia, and Latin America — it has remained listed in Budapest rather than moving its primary listing to a Western European exchange. This has contributed to a structural valuation discount compared to Western European specialty pharma peers with similar product profiles and margins.

Ready to screen 17,000+ stocks?

US, Canada & Europe — free, no sign‑up required.

Related articles

Hungarian Stocks: A Guide to the Budapest Stock Exchange (BÉT) — ScreenerHero